滑膜炎颗粒在膝关节单髁置换术后应用的疗效分析OA
Efficacy analysis of the application of Huamoyan Granules after unicompartmental knee arthroplasty
目的 探讨滑膜炎颗粒在膝关节单髁置换术后应用的临床疗效.方法 选取河北大学附属医院于2023年7月至2024年7月因膝关节骨关节炎行内侧单髁置换术后患者82例,其中应用滑膜炎颗粒患者35例(用药组),未应用患者47例(未用药组),用药组疗程1个月.比较两组患者术前、术后1周疼痛视觉模拟评分(VAS),术前、术后1个月及末次随访膝关节协会评分(KSS),术前及术后3周膝关节活动度(最大屈曲角度、最大伸直角度),术前、术后1周、术后1个月及末次随访的膝关节肿胀程度,以及术前、术后1周血清C反应蛋白(CRP)、红细胞沉降率(ESR)水平.结果 患者均随访6~12个月,平均(8.5±1.8)个月.术后1周,两组VAS评分、膝关节肿胀程度、CRP、ESR均较术前改善,且用药组的VAS评分为(4.03±0.57)分,低于未用药组(5.53±0.65)分,差异有统计学意义(P<0.05);用药组的膝关节肿胀程度为(4.02±1.45)cm,小于未用药组(5.16±1.23)cm,差异有统计学意义(P<0.05);用药组的CRP、ESR分别为(14.36±1.01)mg/L、(39.03±2.17)mm/h,均低于未用药组(15.44±1.30)mg/L、(43.06±3.13)mm/h,差异均有统计学意义(P<0.05).术后3周,两组膝关节最大屈曲角度均大于术前,且用药组为(118.98±11.52)°,大于未用药组(110.81±12.96)°,两组间比较差异有统计学意义(P<0.05);两组膝关节最大伸直角度均小于术前,且用药组为(8.18±3.37)°,小于未用药组(11.19±3.81)°,两组间比较差异有统计学意义(P<0.05).术后1个月,用药组的KSS评分为(82.71±2.50)分,高于未用药组(75.09±2.29)分,差异有统计学意义(P<0.05);用药组膝关节肿胀程度为(1.51±0.79)cm,未用药组为(1.68±0.88)cm,两组差异无统计学意义(P>0.05).末次随访时,两组KSS评分比较,差异无统计学意义(P>0.05).结论 膝关节UKA术后应用滑膜炎颗粒可降低术后早期疼痛及炎症反应,改善术后膝关节功能与活动度,促进早期康复,且未观察到与药物相关的严重不良反应,但对术后3个月及以上的后续膝关节功能无显著改善作用.
Objective To investigate the clinical efficacy of Huamoyan Granules after unicompartmental knee arthroplasty(UKA).Methods A total of 82 patients who underwent medial UKA for knee osteoarthritis(KOA)at Affiliated Hospital of Hebei University from July 2023 to July 2024 were selected.Among them,35 patients received Huamoyan Granules(medication group)for a course of 1 month,while 47 patients did not(non-medication group).The visual analogue scale(VAS)score at pre-operation and 1 week post-operation,the Knee Society Score(KSS)at pre-operation,1 month post-operation,and the last follow-up,knee range of motion(maximum flexion angle,maximum extension angle)at pre-operation and 3 weeks post-operation,knee swelling degree at pre-operation,1 week post-operation,1 month post-operation,and the last follow-up,as well as serum levels of C-reactive protein(CRP)and erythrocyte sedimentation rate(ESR)at pre-operation and 1 week post-operation,were compared between the two groups.Results The patients were followed-up for 6-12 months,with an average of(8.5±1.8)months.At 1 week post-operation,VAS scores,knee swelling degree,CRP,and ESR improved in both groups compared to pre-operative levels.The medication group showed significantly lower VAS scores(4.03±0.57 vs.5.53±0.65),reduced knee swelling(4.02±1.45 cm vs.5.16±1.23 cm),and lower CRP(14.36±1.01 mg/L vs.15.44±1.30 mg/L)and ESR(39.03±2.17 mm/h vs.43.06±3.13 mm/h)compared to the non-medication group(all P<0.05).At 3 weeks post-operation,knee maximum flexion angle improved in both groups versus pre-operation.The medication group achieved a greater flexion angle(118.98±11.52°)than the non-medication group(110.81±12.96°),and a smaller extension lag(8.18±3.37° vs.11.19±3.81°)(all P<0.05).At 1 month post-operation,the KSS was significantly higher in the medication group(82.71±2.50)than in the non-medication group(75.09±2.29)(P<0.05).However,no significant difference was found in knee swelling degree between the two groups(1.51±0.79 cm,1.68±0.88 cm,P>0.05),and no drug-related adverse events occurred during the medication period.At the last follow-up,no significant difference in KSS was observed between the two groups(P>0.05).Conclusion The application of Huamoyan Granules after UKA can reduce early postoperative pain and inflammatory response,improve knee function and range of motion,and promote early rehabilitation with no severe drug-related adverse events observed.However,it does not provide significant additional improvement in mid-term knee function at 3 months or longer post-operation.
李琦;王林;薛金伟
河北大学附属医院骨关节科,河北 保定,071000河北大学附属医院骨关节科,河北 保定,071000||河北大学临床医学院,河北 保定,071000河北大学临床医学院,河北 保定,071000
医药卫生
滑膜炎颗粒骨关节炎膝关节单髁置换术术后
Huamoyan GranulesOsteoarthritis,kneeUnicompartmental knee arthroplastyPostoperative period
《生物骨科材料与临床研究》 2026 (4)
52-57,6
保定市科技计划项目(2341ZF330)
评论